Is ALX Oncology Holdings Inc. overvalued?

ALX Oncology Holdings Inc. (ALXO) — key valuation metrics and fundamentals.

No verdict

Price

$1.39

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$187.0M

Dividend yield

0.0%

Return on equity

-90.3%

Sector

Healthcare

Fair value compares ALXO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks